Encompass Health (EHC), an integrated healthcare services provider operating 166 inpatient rehabilitation hospitals, is identified by Zacks as a top growth stock. The company holds a Zacks #2 (Buy) Rank and an 'A' VGM Score, with a 'B' Growth Style Score, underpinned by an 18.3% forecasted year-over-year earnings growth for the current fiscal year. This outlook is further strengthened by eight analysts revising fiscal 2025 earnings estimates upwards, increasing the Zacks Consensus Estimate to $5.24 per share, and a consistent +14% average earnings surprise, positioning EHC as a compelling opportunity for growth investors.
Encompass Health (EHC) presents a compelling growth profile based on its strong quantitative ratings and positive analyst sentiment. The company, a major provider of inpatient rehabilitation services with 166 hospitals, holds a Zacks #2 (Buy) rank, complemented by an 'A' for its overall VGM Score and a 'B' for Growth. This is substantiated by a forecast for 18.3% year-over-year earnings growth for the current fiscal year. Confidence in its future performance is further reinforced by recent analyst activity, where eight analysts have revised fiscal 2025 earnings estimates upward in the past 60 days, lifting the consensus estimate to $5.24 per share. EHC also has a strong track record of outperformance, historically delivering an average positive earnings surprise of 14%. The company's business model is strategically positioned to benefit from the healthcare industry's shift towards integrated delivery and coordinated care payment models, suggesting a durable long-term tailwind.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
strongly positive
Sentiment Score
0.80
Ticker Sentiment